144 related articles for article (PubMed ID: 16078389)
21. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Chen YI; Huang CS
Stat Med; 2014 Feb; 33(5):786-97. PubMed ID: 24105871
[TBL] [Abstract][Full Text] [Related]
22. Global tests for combination drug studies in factorial trials.
Hung HM
Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
[TBL] [Abstract][Full Text] [Related]
23. Examining outlying subjects and outlying records in bioequivalence trials.
Wang W; Chow SC
J Biopharm Stat; 2003 Feb; 13(1):43-56. PubMed ID: 12635902
[TBL] [Abstract][Full Text] [Related]
24. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
25. Testing equality and interval estimation in binary responses when high dose cannot be used first under a three-period crossover design.
Lui KJ; Chang KC
J Biopharm Stat; 2015; 25(1):190-205. PubMed ID: 24836857
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: use of replicate design approach.
Idkaidek NM; Al-Ghazawi A; Najib NM
Biopharm Drug Dispos; 2004 Dec; 25(9):367-72. PubMed ID: 15495146
[TBL] [Abstract][Full Text] [Related]
27. A method for the evaluation of individual bioequivalence.
Endrenyi L
Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
[TBL] [Abstract][Full Text] [Related]
28. Hypothesis testing and estimation in ordinal data under a simple crossover design.
Lui KJ; Chang KC
J Biopharm Stat; 2012; 22(6):1137-47. PubMed ID: 23075013
[TBL] [Abstract][Full Text] [Related]
29. A new approach for outliers in a bioavailability/bioequivalence study.
Liao JJ
J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
[TBL] [Abstract][Full Text] [Related]
30. Bioequivalence trials with the incomplete 3 x 3 crossover design.
Lim NK; Park SG; Stanek E
Biom J; 2005 Oct; 47(5):635-43. PubMed ID: 16385904
[TBL] [Abstract][Full Text] [Related]
31. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
32. Statistical methods for active extension trials.
Hu Z; Follmann D
Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
[TBL] [Abstract][Full Text] [Related]
33. Crossover trials with a cumulative response.
Walter SD
J Biopharm Stat; 1997 Nov; 7(4):649-66. PubMed ID: 9358336
[TBL] [Abstract][Full Text] [Related]
34. On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints.
Tu D
J Biopharm Stat; 1998 May; 8(2):263-82. PubMed ID: 9598422
[TBL] [Abstract][Full Text] [Related]
35. Multivariate Mann-Whitney estimators for the comparison of two treatments in a three-period crossover study with randomly missing data.
Kawaguchi A; Koch GG
J Biopharm Stat; 2010 Jul; 20(4):720-44. PubMed ID: 20496202
[TBL] [Abstract][Full Text] [Related]
36. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.
Endrenyi L; Tothfalusi L
Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134
[TBL] [Abstract][Full Text] [Related]
37. A Novel Approach to Testing for Average Bioequivalence Based on Modeling the Within-Period Dependence Structure.
Chandrasekhar R; Shi Y; Hutson AD; Wilding GE
J Biopharm Stat; 2015; 25(6):1320-38. PubMed ID: 25671781
[TBL] [Abstract][Full Text] [Related]
38. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
Esinhart JD; Chinchilli VM
J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
[TBL] [Abstract][Full Text] [Related]
39. Permutation test following covariate-adaptive randomization in randomized controlled trials.
Hasegawa T; Tango T
J Biopharm Stat; 2009; 19(1):106-19. PubMed ID: 19127470
[TBL] [Abstract][Full Text] [Related]
40. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
Shen M; Russek-Cohen E; Slud EV
Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
